Professor of MedicineDivision of Hematology, University of North Carolina at Chapel HillChapel Hill, North Carolina, United States
OC 26.4 - Questioning the benefit of Caplacizumab for the treatment of acquired Thrombotic Thrombocytopenic Purpura: a real-world, single center experience
Sunday, June 23, 202415:30 – 15:45 ICT
PB0579 - Safety of continuous long term antifibrinolytic therapy in patients with Hereditary Hemorrhagic Telangiectasia
Monday, June 24, 202413:45 – 14:45 ICT